Learn About Genital Herpes - Your Guide To Manage Herpes In Your Life
|
Herpes Ii Article
![]()
This is a selection made from among articles on Herpes Ii. For a permanent link to this article, or to bookmark it for future reading, click here.
Managing herpes
from:Herpes, an infection caused by the herpes simplex virus, is
estimated to be present in 50 to 80 percent of the American
adult population. 20 percent, over 50 million people, are
infected with genital herpes, also caused by the herpes simplex
virus, and the majority of these cases may be unaware they even
have it. Studies show that more than 500,000 Americans are
diagnosed with genital herpes each year, and the largest
increase is occurring in young teens. Some people are trying to
self diagnose themselfs by using herpes pictures see:
http://www.nicocure-guide.com/herpes-pictures ,
but the only right thing is to be diagnosed by specialist for
right treatment. There is no cure for herpes to date. Supporting
your immune system should be your first goal. A weakened immune
system is more prone to outbreaks.Efforts to develop a herpes
vaccine by biotechnology companies are ongoing. Until an
effective herpes vaccine or cure for HSV infection is found, the
prevailing approach to treatment continues to be suppressive
antiviral therapy. Although there is no cure for herpes, some
drugs have been effective in reducing the frequency and duration
of outbreaks. It might be a good idea to discuss options with
your doctor. During an outbreak, keep the infected area as clean
and dry as possible. This will help your natural healing
processes. Some doctors recommend warm showers in order to
cleanse the infected area. Afterwards, towel dry gently, or dry
the area with a hair dryer on a low or cool setting. To prevent
chaffing, some people also find it helpful to avoid
tight-fitting undergarments. Most creams and lotions do no good
and may even irritate.
Herpes Ii News
Vical's Herpes Simplex Vaccines Protect Against Lethal Challenge and ... - MarketWatch (press release)
Vical's Herpes Simplex Vaccines Protect Against Lethal Challenge and ... MarketWatch (press release) HSV-2 is a sexually transmitted virus which is the leading cause of genital herpes. Approximately one out of every six individuals in the United States and ... |
Centaur Pharmaceuticals In-Licenses Herpes Drug Sorivudine from aRigen ... - Business Wire India (press release)
Centaur Pharmaceuticals In-Licenses Herpes Drug Sorivudine from aRigen ... Business Wire India (press release) ... India (DCGI) for permission for Phase II and Phase III trials and for marketing rights in India. Sorivudine is a local application, for Herpes Zoster, ... |
Inhibitex Reports Independent Data Safety Monitoring Board Recommends ... - MarketWatch (press release)
Inhibitex Reports Independent Data Safety Monitoring Board Recommends ... MarketWatch (press release) The Phase II trial is a well-controlled, double-blind study comparing two arms of FV-100 to an active control (valacyclovir) in the treatment of shingles, ... |
Oncolytics Begins Final Tests On Viral Cancer Drug >ONC.T - Wall Street Journal
Oncolytics Begins Final Tests On Viral Cancer Drug >ONC.T Wall Street Journal Massachusetts-based Biovex Inc. is two-thirds of the way through a Phase III trial using a modified herpes virus to treat melanoma, and expects results in a ... |
Studies show promise in curbing AIDS in Africa - Los Angeles Times
Studies show promise in curbing AIDS in Africa Los Angeles Times For the first time in the bleak history of the AIDS epidemic on the African continent, researchers have identified ... |






